Syra Health Corp. Class A (SYRA)
NASDAQ:SYRA
US Market
Holding SYRA?
Track your performance easily

Syra Health Corp. Class A (SYRA) Stock Price & Analysis

50 Followers

SYRA Stock Chart & Stats


Financials

Annual

Ownership Overview

18.14%66.40%11.14%9816.30%
18.14% Insiders
11.14% Other Institutional Investors
9816.30% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

SYRA FAQ

What was Syra Health Corp. Class A’s price range in the past 12 months?
Syra Health Corp. Class A lowest stock price was $0.34 and its highest was $8.37 in the past 12 months.
    What is Syra Health Corp. Class A’s market cap?
    Currently, no data Available
    When is Syra Health Corp. Class A’s upcoming earnings report date?
    Syra Health Corp. Class A’s upcoming earnings report date is Nov 12, 2024 which is in 5 days.
      How were Syra Health Corp. Class A’s earnings last quarter?
      Syra Health Corp. Class A released its earnings results on Aug 08, 2024. The company reported -$0.21 earnings per share for the quarter, missing the consensus estimate of -$0.19 by -$0.02.
        Is Syra Health Corp. Class A overvalued?
        According to Wall Street analysts Syra Health Corp. Class A’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Syra Health Corp. Class A pay dividends?
          Syra Health Corp. Class A does not currently pay dividends.
          What is Syra Health Corp. Class A’s EPS estimate?
          Syra Health Corp. Class A’s EPS estimate is -$0.21.
            How many shares outstanding does Syra Health Corp. Class A have?
            Syra Health Corp. Class A has 8,973,774 shares outstanding.
              What happened to Syra Health Corp. Class A’s price movement after its last earnings report?
              Syra Health Corp. Class A reported an EPS of -$0.21 in its last earnings report, missing expectations of -$0.19. Following the earnings report the stock price went up 1.55%.
                Which hedge fund is a major shareholder of Syra Health Corp. Class A?
                Currently, no hedge funds are holding shares in SYRA
                ---

                Syra Health Corp. Class A Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Fundamentals

                Return on Equity
                -688.49%
                Trailing 12-Months
                Asset Growth
                80.39%
                Trailing 12-Months

                Company Description

                Syra Health Corp. Class A

                Syra Health Corp. is a healthcare services company. The Company offers comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health. The Company within its health education service line offers services, including medical communications, patient education, and healthcare training. Its population health management services include analytics as a service, epidemiology and health equity analytics solutions. The Company¿s digital health solutions include digital transformation, cloud and security, artificial intelligence, patient engagement, and health applications. The Company provides workforce staffing solutions, health education and healthcare research consulting services to mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities and pharmaceutical manufacturers.
                ---

                SYRA Earnings Call

                Q1 2024
                0:00 / 0:00
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Burning Rock Biotech
                Prophase Labs
                TRACON Pharmaceuticals
                Sonoma Pharmaceuticals
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis